Valuation Traphaco

Stocks

End-of-day quote Ho Chi Minh S.E. 08/09/2026			5-day change	1st Jan Change
37,000.00 ^VND	+0.27%		0.00%	-1.33%

08-27	Traphaco Joint Stock Company Appoints Nguyen Phu Khanh as Chief Finance Officer, Effective August 25, 2026	CI
08-27	Traphaco Joint Stock Company Appoints Nguy?n Phú Khánh as Chief Finance & Planning Officer, Effective August 25, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,967,859	3,780,289	3,689,098	3,689,098	3,253,867	3,108,790
Change	-	27.37%	-2.41%	0%	-11.8%	-4.46%
Enterprise Value (EV) ¹	2,627,509	3,309,117	3,227,397	3,074,674	2,713,414	2,539,407
Change	-	25.94%	-2.47%	-4.73%	-11.75%	-6.41%
P/E	17.1x	17.6x	15.6x	16.1x	15.7x	14.3x
PBR	2.75x	3.24x	2.89x	2.67x	2.29x	2x
PEG	-	0.7x	1.57x	-5.88x	-1.59x	2.97x
Capitalization / Revenue	1.55x	1.75x	1.54x	1.6x	1.39x	1.17x
EV / Revenue	1.38x	1.53x	1.35x	1.34x	1.16x	0.96x
EV / EBITDA	7.52x	8.09x	7.43x	7.25x	6.89x	6.16x
EV / EBIT	9.77x	10.1x	9.21x	9.22x	8.85x	7.84x
EV / FCF	9.66x	12.6x	32x	12.4x	47x	42.2x
FCF Yield	10.4%	7.92%	3.12%	8.06%	2.13%	2.37%
Dividend per Share ²	1,500	1,500	1,500	2,000	2,000	-
Rate of return	4.19%	3.29%	3.37%	4.49%	5.1%	-
EPS ²	2,092	2,588	2,845	2,768	2,495	2,615
Distribution rate	71.7%	57.9%	52.7%	72.3%	80.2%	-
Net sales ¹	1,908,870	2,160,840	2,398,918	2,299,235	2,347,221	2,657,210
EBITDA ¹	349,535	408,895	434,258	424,189	394,063	412,206
EBIT ¹	269,072	326,581	350,578	333,373	306,455	323,920
Net income ¹	195,787	241,591	269,145	263,248	239,017	249,655
Net Debt ¹	-340,350	-471,173	-461,701	-614,424	-540,453	-569,384
Reference price ²	35,800.00	45,600.00	44,500.00	44,500.00	39,250.00	37,500.00
Nbr of stocks (in thousands)	82,901	82,901	82,901	82,901	82,901	82,901
Announcement Date	3/8/21 A	3/11/22 A	3/29/23 A	3/21/24 A	3/28/25 A	3/26/26 A

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TRAPHACO	-	-	-	-	117M
ELI LILLY AND COMPANY	32.72x	11.9x	24.26x	0.6%	1,024B
JOHNSON & JOHNSON	30.62x	-	-	1.95%	663B
ABBVIE INC.	32.73x	7.6x	15.8x	2.67%	453B
ROCHE HOLDING AG	19.22x	4.69x	11.6x	2.83%	349B
NOVARTIS AG	22.02x	5.68x	14.1x	2.82%	295B
ASTRAZENECA PLC	20.97x	4.3x	12.3x	2.05%	253B
AMGEN INC.	27.66x	7.14x	13.16x	2.31%	236B
NOVO NORDISK A/S	13.33x	4.82x	10.06x	3.78%	206B
GILEAD SCIENCES, INC.	-46.14x	6.65x	25.95x	2.18%	187B
Average	17.01x	6.60x	15.90x	2.35%	366.74B
Weighted average by Cap.	23.94x	7.98x	17.77x	1.96%